What is SIRIC CARPEM?
CARPEM is an Integrated Cancer Research Site (SIte de Recherche Intégrée sur le Cancer – SIRIC) focused on the development of new personalized cancer treatments while working on prevention.
SIRIC were established by the National Cancer Institute (INCa). The SIRIC label of our the CARPEM program is an acknowledgement of the excellence of cancer research of our research and clinic teams that have significant expertise in translational research. Translational research is essential to make the link between basic research (basic mechanisms)
and clinical research (medical application).
To achieve our goals, we gathered the oncology strengths of 3 major AP-HP hospitals
(Georges Pompidou, Cochin and Necker).
CARPEM SIRIC brings together 350 doctors and researchers dedicated to care and research.
translational research in cancerology
21 research teams
11 clinical teams
The 3 programs
Immunity & Environment
The first challenge is to integrate metabolism in its broad sense, ranging from risk factors related to the lifestyle (physical inactivity, obesity, eating habits…) to molecular mechanisms induced in tumor cells or immune cells…
Cancer heterogeneity : a challenge for patient management
The second challenge consists in the comprehensive study of tumors heterogeneity which plays an important role in cancer treatment resistance and constitutes the next frontier for developing an effective precision medicine…
and health democracy
This program addresses technical, clinical and ethical challenges of integration and sharing of data generated on a large scale by the technical advances implemented in both research and healthcare. This essential step requires the adherence of patients and their families to become active players in cancer research…
We federate 10 clinical teams from 3 major Parisian hospitals (HEGP, Cochin and Necker) that work on a large spectrum of cancers…
21 research teams working in the most famous Parisian institutes are dedicated to research against cancer…